Gullans Steven R. Ph.D.

CIK 00015719974 companiesBOSTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001571997

Recent Transactions

30 trades

Award
iSpecimen Inc.$ISPC
Option
2024-01-02$0.53/sh+10,000→ 33,525 total
Award
iSpecimen Inc.$ISPC
Option
2023-01-03$1.41/sh+10,000→ 23,525 total
Award
iSpecimen Inc.$ISPC
Common Stock
2023-01-01+125→ 3,250 total
Award
iSpecimen Inc.$ISPC
Common Stock
2022-10-01+625→ 3,125 total
Award
iSpecimen Inc.$ISPC
Non-Qualified Stock Options
2021-07-30+13,525→ 13,525 total
Award
iSpecimen Inc.$ISPC
Common Stock
2021-07-30+2,500→ 2,500 total
Award
MetaVia Inc.$MTVA
Non-qualified stock option (right to buy)
2020-01-13+60,000→ 60,000 total
Award
MetaVia Inc.$MTVA
Common Stock
2019-07-24+300,000→ 300,000 total
Award
MetaVia Inc.$MTVA
Employee Stock Option (right to buy)
2018-05-22+50,000→ 50,000 total
Award
MetaVia Inc.$MTVA
Employee Stock Option (right to buy)
2018-05-22+50,000→ 50,000 total
Award
MetaVia Inc.$MTVA
Employee Stock Option (right to buy)
2018-05-01+150,000→ 150,000 total
Purchase
MetaVia Inc.$MTVA
Common Stock
2018-02-08$7.00/sh+71,429→ 930,252 total
Award
MetaVia Inc.$MTVA
Employee Stock Option (right to buy)
2018-01-29+60,000→ 60,000 total
Conversion
Rein Therapeutics, Inc.$RNTX
Series F Preferred Stock
2017-07-05−1,083,119→ 0 total
Conversion
Rein Therapeutics, Inc.$RNTX
Common Stock
2017-07-05+956,100→ 956,100 total
Conversion
Rein Therapeutics, Inc.$RNTX
Series E-2 Preferred Stock
2017-07-05−1,329,993→ 0 total
Conversion
Rein Therapeutics, Inc.$RNTX
Series D Preferred Stock
2017-07-05−5,934,050→ 0 total
Purchase
Rein Therapeutics, Inc.$RNTX
Common Stock
2017-07-05$15.00/sh+60,000→ 1,016,100 total
Conversion
Rein Therapeutics, Inc.$RNTX
Series E-3 Preferred Stock
2017-07-05−1,153,606→ 0 total
Award
MetaVia Inc.$MTVA
Employee Stock Option (right to buy)
2017-05-30+60,000→ 60,000 total
Purchase
MetaVia Inc.$MTVA
Common Stock
2017-03-10$9.47/sh+52,798→ 858,823 total
Purchase
MetaVia Inc.$MTVA
Warrant to Purchase Common Stock
2017-03-10$9.47/sh+39,599→ 39,599 total
Conversion
MetaVia Inc.$MTVA
8% Convertible Subordinated Promissory Note
2016-08-10→ 0 total
Conversion
MetaVia Inc.$MTVA
Common Stock
2016-08-10$6.71/sh+306,025→ 306,025 total
Purchase
MetaVia Inc.$MTVA
Common Stock
2016-08-10$10.00/sh+500,000→ 806,025 total
Award
MetaVia Inc.$MTVA
Stock Option (right to buy)
2016-08-04+60,000→ 60,000 total
Conversion
TETRAPHASE PHARMACEUTICALS INC
Series C Convertible Participating Preferred Stock
2013-03-25−28,199,144→ 0 total
Award
TETRAPHASE PHARMACEUTICALS INC
Non-qualified stock option (right to buy)
2013-03-25+20,000→ 20,000 total
Conversion
TETRAPHASE PHARMACEUTICALS INC
Common Stock
2013-03-25+972,384→ 972,384 total
Purchase
TETRAPHASE PHARMACEUTICALS INC
Common Stock
2013-03-25$7.00/sh+496,121→ 1,468,505 total

Companies

Recent Filings

Address

800 BOYLSTON ST. SUITE 2825

BOSTON, MA, 02199

View on SEC.gov